EVOLUTION OF ENZYMATIC MECHANISMS OF RESISTANCE AMONG BETA-LACTAM ANTIBIOTICS

被引:0
作者
GUTMANN, L [1 ]
KITZIS, MD [1 ]
ACAR, JF [1 ]
机构
[1] HOP ST JOSEPH,MED MICROBIOL LAB,F-75674 PARIS 14,FRANCE
关键词
CHROMOSOMAL CEPHALOSPORINASE; BROAD-SPECTRUM PLASMID-MEDIATED BETA-LACTAMASES; ENZYME INHIBITORS; PENICILLIN-BINDING PROTEINS;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Resistance to third-generation cephalosporins occurs as a result of either the production of high concentrations of chromosomal cephalosporinase or, increasingly, the presence of broad-spectrum plasmid-mediated beta-lactamases. Both cases represent the response of bacteria in the hospital setting to the selection pressure brought to bear by the use of these antibiotics. Continued evolution of the plasmid-mediated enzymes is occurring as new antibiotics are introduced, probably reflecting the process that began when the first beta-lactamase apparently evolved from the penicillin-binding proteins. beta-Lactamase inhibitors offer one approach to dealing with the evolution of resistance to previously beta-lactamase-stable antibiotics.
引用
收藏
页码:D37 / D47
页数:11
相关论文
共 50 条
[31]   A high-resolution screen identifies a preexisting beta-lactam that specifically treats Lyme disease in mice [J].
Gabby, Maegan E. ;
Bandara, Abey ;
Outrata, L. M. ;
Ebohon, Osamudiamen ;
Ahmad, Saadman S. ;
Dressler, Jules M. ;
Mcclune, Mecaila E. ;
Trimble, Rebecca N. ;
Mullen, Lainey ;
Jutras, Brandon L. .
SCIENCE TRANSLATIONAL MEDICINE, 2025, 17 (795)
[32]   Mutation Landscape of Acquired Cross-Resistance to Glycopeptide and β-Lactam Antibiotics in Enterococcus faecium [J].
Sacco, Emmanuelle ;
Cortes, Melanie ;
Josseaume, Nathalie ;
Bouchier, Christiane ;
Dubee, Vincent ;
Hugonnet, Jean-Emmanuel ;
Mainardi, Jean-Luc ;
Rice, Louis B. ;
Arthur, Michel .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (09) :5306-5315
[33]   β-Lactam antibiotic targets and resistance mechanisms: from covalent inhibitors to substrates [J].
Mora-Ochomogo, Montserrat ;
Lohans, Christopher T. .
RSC MEDICINAL CHEMISTRY, 2021, 12 (10) :1623-1639
[34]   Mass-Spectrometry Analysis of Genetic Markers of S-pneumoniae Resistance to β-Lactam Antibiotics [J].
Savinova, T. A. ;
Il'ina, E. N. ;
Sidorenko, S. V. .
MOLECULAR GENETICS MICROBIOLOGY AND VIROLOGY, 2010, 25 (03) :106-117
[35]   Elevating NagZ Improves Resistance to β-Lactam Antibiotics via Promoting AmpC β-Lactamase in Enterobacter cloacae [J].
Yang, Xianggui ;
Zeng, Jun ;
Zhou, Qin ;
Yu, Xuejing ;
Zhong, Yuanxiu ;
Wang, Fuying ;
Du, Hongfei ;
Nie, Fang ;
Pang, Xueli ;
Wang, Dan ;
Fan, Yingzi ;
Bai, Tingting ;
Xu, Ying .
FRONTIERS IN MICROBIOLOGY, 2020, 11
[36]   Impact of respiratory syncytial virus on Streptococcus pneumoniae resistance to β-lactam antibiotics: an investigative study in children [J].
Li, Lu ;
Wan, Yushun ;
Wang, Yuncheng ;
Tao, Ye ;
Long, Xiao ;
Liu, Enmei ;
Deng, Yu .
BMC MICROBIOLOGY, 2025, 25 (01)
[37]   Mechanisms of β-lactam resistance of Streptococcus uberis isolated from bovine mastitis cases [J].
McDougall, Scott ;
Clausen, Laura ;
Ha, Hye-Jeong ;
Gibson, Isobel ;
Bryan, Mark ;
Hadjirin, Nazreen ;
Lay, Elizabeth ;
Raisen, Claire ;
Ba, Xiaoliang ;
Restif, Olivier ;
Parkhill, Julian ;
Holmes, Mark A. .
VETERINARY MICROBIOLOGY, 2020, 242
[38]   Effectiveness of Antipseudomonal Antibiotics and Mechanisms of Multidrug Resistance in Pseudomonas aeruginosa [J].
El Zowalaty, Mohamed E. ;
Gyetvai, Bela .
POLISH JOURNAL OF MICROBIOLOGY, 2016, 65 (01) :23-32
[39]   Sublethal β-lactam antibiotics induce PhpP phosphatase expression and StkP kinase phosphorylation in PBP-independent β-lactam antibiotic resistance of Streptococcus pneumoniae [J].
Huang, Yan-Ying ;
Sun, Yan-Hong ;
Huang, Nan ;
Liu, Xiao-Xiang ;
Yan, Jie ;
Sun, Ai-Hua .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 503 (03) :2000-2008
[40]   Infectious disease: how to manage Gram-positive and Gram-negative pathogen conundrums with dual beta-lactam therapy [J].
FakhriRavari, Alireza ;
Simiyu, Brenda ;
Morrisette, Taylor ;
Dayo, Yewande ;
Abdul-Mutakabbir, Jacinda C. .
DRUGS IN CONTEXT, 2022, 11